907 resultados para Care to RMT victims
Resumo:
Newsletter produced by Iowa Veterans Home. To provide a continuum of information and care to Iowa’s veterans and their spouses in an environment focusing on individualized services to enhance their quality of life.
Resumo:
Newsletter produced by Iowa Veterans Home. To provide a continuum of information and care to Iowa’s veterans and their spouses in an environment focusing on individualized services to enhance their quality of life.
Resumo:
Newsletter produced by Iowa Veterans Home. To provide a continuum of information and care to Iowa’s veterans and their spouses in an environment focusing on individualized services to enhance their quality of life.
Resumo:
Newsletter produced by Iowa Veterans Home. To provide a continuum of information and care to Iowa’s veterans and their spouses in an environment focusing on individualized services to enhance their quality of life.
Resumo:
Newsletter produced by Iowa Veterans Home. To provide a continuum of information and care to Iowa’s veterans and their spouses in an environment focusing on individualized services to enhance their quality of life.
Resumo:
Newsletter produced by Iowa Veterans Home. To provide a continuum of information and care to Iowa’s veterans and their spouses in an environment focusing on individualized services to enhance their quality of life.
Resumo:
Newsletter produced by Iowa Veterans Home. To provide a continuum of information and care to Iowa’s veterans and their spouses in an environment focusing on individualized services to enhance their quality of life.
Resumo:
Newsletter produced by Iowa Veterans Home. To provide a continuum of information and care to Iowa’s veterans and their spouses in an environment focusing on individualized services to enhance their quality of life.
Resumo:
Newsletter produced by Iowa Veterans Home. To provide a continuum of information and care to Iowa’s veterans and their spouses in an environment focusing on individualized services to enhance their quality of life.
Resumo:
Newsletter produced by Iowa Veterans Home. To provide a continuum of information and care to Iowa’s veterans and their spouses in an environment focusing on individualized services to enhance their quality of life.
Resumo:
To provide a continuum of information and care to Iowa’s veterans and their spouses in an environment focusing on individualized services to enhance their quality of life.
Resumo:
PURPOSE: Recurrent head and neck cancer is associated to a poor survival prognosis. A high toxicity rate is demonstrated when surgery and/or radiotherapy and/or chemotherapy are combined. Furthermore, the duration of treatment is often not ethically compatible with the expected survival (median survival<1year). Normal tissues tolerance limits the use of reirradiation and stereotactic body radiotherapy (SBRT) could offer precise irradiation while sparing healthy tissues. After completion of a feasibility study, results of a multicentric study (Lille, Nancy & Nice) using SBRT with cetuximab are reported. The aim of the study was to deliver non toxic short course SBRT (2weeks) in order to get the same local control as the one demonstrated with longer protocols. METHODS AND MATERIALS: Patients with inoperable recurrent, or new primary tumor in a previously irradiated area, were included (WHO<3). Reirradiation (RT) dose was 36Gy in six fractions of 6Gy to the 85% isodose line covering 95% of the PTV with 5 injections of concomitant cetuximab (CT). All patients had previous radiotherapy, 85% had previous surgery and 48% previous chemotherapy. RESULTS: Between 11/2007 and 08/2010, 60 were included (46 men and 14 women), 56 received CT+RT, 3 were not treated and 1 received only CT. Median age was 60 (42-87)) and all 56 patients had squamous carcinoma and received concomitant cetuximab. Mean time between previous radiotherapy and the start of SBRT was 38months. Cutaneous toxicity was observed for 41 patients. There was one toxic death from hemorrhage and denutrition. Median follow-up was 11.4months. At 3months, response rate was 58.4% (95% CI: 43.2-72.4%) and disease control rate was 91.7% (95% CI: 80.0-97.7%). The one-year OS rate was 47.5% (95% CI: 30.8-62.4). CONCLUSION: These results suggest that short SBRT with cetuximab is an effective salvage treatment with good response rate in this poor prognosis population with previously irradiated HNC. Treatment is feasible and, with appropriate care to limiting critical structure, acute toxicities are acceptable. This combination may be the reference treatment is this population.
Resumo:
Des de 1999, el Departament de Justícia aplica el Programa de mediació penal amb infractors adults i víctimes. Aquest Programa, emmarcat en la perspectiva de l’anomenada Justícia Restaurativa, cerca resoldre el conflicte produït pel delicte implicant totes les parts i concedint un paper clau a la víctima, sobre la restitució de la qual gira el procés mediador. La recerca que es presenta fa una avaluació del funcionament d’aquest Programa amb l’objectiu de constatar si la mediació penal pot satisfer algunes de les necessitats de les víctimes de delictes. La valoració que en fan les víctimes que han participat en l’estudi d’avaluació és positiva. Els principals beneficis que destaquen són la reparació material, rebre les disculpes de l’infractor, poder explicar la seva vivència i sentir-se escoltades, i poder participar en la resolució del seu propi procediment i en la resolució final del conflicte.
Resumo:
Desde 1999, el Departamento de Justicia de la Generalitat de Cataluña aplica el Programa de mediación penal con infractores adultos y víctimas. Este Programa, enmarcado en la perspectiva de la llamada Justicia Restaurativa, busca resolver el conflicto producido por el delito implicando a todas las partes y concediendo un papel clave a la víctima, sobre la restitución de la cual gira el proceso mediador. La investigación que se presenta hace una evaluación del funcionamiento de este Programa con el objetivo de constatar si la mediación penal puede satisfacer algunas de las necesidades de las víctimas de delitos. La valoración que hacen las víctimas que han participado en el estudio de evaluación es positiva. Los principales beneficios que destacan son la reparación material, recibir las disculpas del infractor, poder explicar su vivencia y sentirse escuchadas, y poder participar en la resolución de su propio procedimiento y en la resolución final del conflicto.
Resumo:
Tuberculosis is unique among the major infectious diseases in that it lacks accurate rapid point-of-care diagnostic tests. Failure to control the spread of tuberculosis is largely due to our inability to detect and treat all infectious cases of pulmonary tuberculosis in a timely fashion, allowing continued Mycobacterium tuberculosis transmission within communities. Currently recommended gold-standard diagnostic tests for tuberculosis are laboratory based, and multiple investigations may be necessary over a period of weeks or months before a diagnosis is made. Several new diagnostic tests have recently become available for detecting active tuberculosis disease, screening for latent M. tuberculosis infection, and identifying drug-resistant strains of M. tuberculosis. However, progress toward a robust point-of-care test has been limited, and novel biomarker discovery remains challenging. In the absence of effective prevention strategies, high rates of early case detection and subsequent cure are required for global tuberculosis control. Early case detection is dependent on test accuracy, accessibility, cost, and complexity, but also depends on the political will and funder investment to deliver optimal, sustainable care to those worst affected by the tuberculosis and human immunodeficiency virus epidemics. This review highlights unanswered questions, challenges, recent advances, unresolved operational and technical issues, needs, and opportunities related to tuberculosis diagnostics.
